Khanani AM, Brown DM, Jaffe GJ, Wykoff CC, et al. MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants With nAMD and Persistent Retinal Fluid. Ophthalmology 2022 May 7. pii: S0161-6420(22)00334.
PMID: 35537533